Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3256 AL 3270

Recognizing Movement Disorder Emergencies - A Practical Review For Non-Neurologist

Hakeem H, Nasir M, Khan MF, Syed NM, Rajput HM, Ahmed A, Javed MA, Bhatti DE.

J Ayub Med Coll Abbottabad. 2019 Jul-Sep;31(3):448-453.

ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder

Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ.

Mov Disord Clin Pract. 2019 Aug 19;6(7):512-520. doi: 10.1002/mdc3.12816. eCollection 2019 Sep.

Efficacy of Deep Brain Stimulation in a Patient with Genetically Confirmed Chorea-Acanthocytosis

Richard A, Hsu J, Baum P, Alterman R, Simon DK.

Case Rep Neurol. 2019 Jun 26;11(2):199-204. doi: 10.1159/000500951. eCollection 2019 May-Aug.

Parkinsonism with a Hint of Huntington's from 29 CAG Repeats in HTT

Jot S.

Brain Sci. 2019 Sep 22;9(10):245. doi: 10.3390/brainsci9100245.

Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases

Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I.

Front Neurosci. 2019 Aug 28;13:862. doi: 10.3389/fnins.2019.00862. eCollection 2019.

Biomedical Implications of Autophagy in Macromolecule Storage Disorders

Palhegyi AM, Seranova E, Dimova S, Hoque S, Sarkar S.

Front Cell Dev Biol. 2019 Sep 6;7:179. doi: 10.3389/fcell.2019.00179. eCollection 2019.

Neuroinflammation as a Common Feature of Neurodegenerative Disorders

Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N.

Front Pharmacol. 2019 Sep 12;10:1008. doi: 10.3389/fphar.2019.01008. eCollection 2019.

NAD(+) in Brain Aging and Neurodegenerative Disorders

Lautrup S, Sinclair DA, Mattson MP, Fang EF.

Cell Metab. 2019 Oct 1;30(4):630-655. doi: 10.1016/j.cmet.2019.09.001.

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

Leitner GR, Wenzel TJ, Marshall N, Gates EJ, Klegeris A.

Expert Opin Ther Targets. 2019 Oct;23(10):865-882. doi: 10.1080/14728222.2019.1676416. Epub 2019 Oct 20.

Is Huntington's disease on the threshold of a new era in treatment?

Sandy S, Richard A.

Neurodegener Dis Manag. 2019 Oct;9(5):255-258. doi: 10.2217/nmt-2019-0015.

Astrocytes in Huntington's Disease

Gray M.

Adv Exp Med Biol. 2019;1175:355-381. doi: 10.1007/978-981-13-9913-8_14.

The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease

Cheong RY, Gabery S, Petersén Å.

J Huntingtons Dis. 2019;8(4):375-391. doi: 10.3233/JHD-190372.

Computational insights into lipid assisted peptide misfolding and aggregation in neurodegeneration

Sahoo A , Matysiak S .

Phys Chem Chem Phys. 2019 Oct 24;21(41):22679-22694. doi: 10.1039/c9cp02765c.

Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases

Bohush A, Bieganowski P, Filipek A.

Int J Mol Sci. 2019 Oct 9;20(20):4976. doi: 10.3390/ijms20204976.

Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings

Elsaid S, Kloiber S, Le Foll B.

Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias